SESSION IIb - Parallel session (Carmel Room) Menstrual fluid: non-invasive source of endometrial tissue for organoids and diagnostics Identification of a novel neuroendocrine pathway and its role in endometriosis-related infertility Pros and cons of hormonal interventions for endometriosis and Christine Metz, Ph.D.ĪI-driven early detection of endometriosis from observational clinical data Single-cell analysis of menstrual endometrial tissues defines phenotypes associated with endometriosis SESSION IIa - Parallel session (Einhorn Auditorium) #Enzian classification, an essential tool for surgical management of severe endometriosis. Leveraging the Immune System to Treat Endometriosis Laporoscopic hysterectomy: How it was and how it is Management of Endometriosis During Hysterectomy SESSION I - Joint session (Einhorn Auditorium) Amanda Chu, MD, Seckin Endometriosis Center.Karli Goldstein, MD, board member, Endometriosis Foundation of America (EndoFound).Harry Reich, MD., Honorary Medical Director Emeritus and Senior Medical Advisor to EndoFound.Piraye Beim, Ph.D., Founder and CEO, Celmatix.Tamer Seckin, MD., co-founder of Endometriosis Foundation of America (EndoFound).
Dan Martin, MD., Scientific & Medical Director, Endometriosis Foundation of America (EndoFound).While COVID-19 is still among us, we are hopeful we will have a safe and productive meeting with the appropriate precautions. We have longed to have an in-person meeting where faculty and participants can talk, laugh, and brainstorm face-to-face. The two-day conference is on April 1-2, 2023 at Einhorn Auditorium, Lenox Hill Hospital, NYC. Therefore, this conference will target this important topic. While significant discoveries are being made in endometriosis at the molecular level, they have yet to be translated into tests and therapeutics that can improve the standard of care. With great excitement, we invite you to EndoFound’s 14th Annual Scientific Conference – Endometriosis 2023: From Molecular Fingerprints to Multiorgan Complex Surgery
0 kommentar(er)
